首页> 外文期刊>Organometallics >1 H -1,2,3-Triazole-tethered isatin-ferrocene and isatin-ferrocenylchalcone conjugates: Synthesis and in vitro antitubercular evaluation
【24h】

1 H -1,2,3-Triazole-tethered isatin-ferrocene and isatin-ferrocenylchalcone conjugates: Synthesis and in vitro antitubercular evaluation

机译:1 H -1,2,3-三唑系的异丁二茂铁和异丁二茂铁查尔酮共轭物:合成和体外抗结核评估

获取原文
获取原文并翻译 | 示例
           

摘要

A Cu-mediated azide-alkyne cycloaddition protocol has been employed for the synthesis of 16 different triazoles to probe the antitubercular structure-activity relationships within the isatin-ferrocene-triazole conjugate family. The antitubercular evaluation studies revealed a marked improvement in activity with the introduction of ferrocene nucleus among precursors N-alkylazido isatins with a prefernce for halogen (F, Cl) substituent at C-5 position of isatin as well as propyl chain length as a spacer. The induction of a chalcone nucleus resulted in the enhanced antimycobacterial efficacy irrespective of the subtituent and alkyl chain length as evidenced by the isatin-ferrocenylchalcone hybrids. The described protocol is the first successful attempt of the amalgamation of ferrocene-isatin nuclei tethered via a triazole linker.
机译:铜介导的叠氮化物-炔烃环加成方案已用于合成16种不同的三唑,以探究伊斯汀-二茂铁-三唑共轭物家族中的抗结核结构-活性关系。抗结核评估研究表明,在前体N-烷基叠氮基靛红中引入二茂铁原子核后,活性显着提高,并且在其C-5位上首选卤素(F,Cl)取代基以及以丙基链长作为间隔基。查尔酮核的诱导导致增强的抗分枝杆菌功效,而不论取代基和烷基链长如何,如伊斯汀-二茂铁基查耳酮杂种所证明的。所描述的协议是通过三唑连接子拴系的二茂铁-isatin核的合并的首次成功尝试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号